NeuroPace Inc (NPCE): Cash & Equivalents

Annual figures by period end, from SEC filings.

$21.69M
As of 2025-12-31
$12.54M
As of 2026-06-30
+48.6%
3-year compound annual growth
-3.8%
5-year compound annual growth
$26.39M2020-12-31: $26.39M2021-12-31: $19.19M2022-12-31: $6.61M2023-12-31: $18.06M2024-12-31: $13.43M2025-12-31: $21.69M$21.69M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$21.69M+61.5%2026-03-03, Balance as of period end
2024-12-31$13.43M-25.6%2026-03-03, Balance as of period end
2023-12-31$18.06M+173.4%2025-03-04, Balance as of period end
2022-12-31$6.61M-65.6%2024-03-05, Balance as of period end
2021-12-31$19.19M-27.3%2023-03-02, Balance as of period end
2020-12-31$26.39Mn/a2022-03-10, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
NeuroPace Inc (NPCE)2025-12-31$21.69M+61.5%
Beta Bionics, Inc. (BBNX)2025-12-31$31.58M+3.8%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$99.71M-58.0%
Pulmonx Corp (LUNG)2025-12-31$69.75M-1.6%
Anika Therapeutics, Inc. (ANIK)2025-12-31$57.48M+3.3%
Orasure Technologies Inc (OSUR)2025-12-31$199.28M-25.6%
Delcath Systems, Inc. (DCTH)2025-12-31$43.45M+34.1%
Iradimed Corp (IRMD)2025-12-31$51.16M-2.1%
TELA Bio, Inc. (TELA)2025-12-31$50.84M-3.5%

Compare NPCE, BBNX, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗